Want full text access to this journal?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign UpAnnals of the Rheumatic Diseases
• journal#1
LETTER
Emanuel Della-Torre, Marco Lanzillotta, Mona-Rita Yacoub
No abstract text is available yet for this article.
January 14, 2020: Annals of the Rheumatic Diseases
#2
LETTER
Young Ho Lee
No abstract text is available yet for this article.
January 10, 2020: Annals of the Rheumatic Diseases
#3
Jun Inamo
No abstract text is available yet for this article.
January 10, 2020: Annals of the Rheumatic Diseases
#4
REVIEW
Annette van der Helm-van Mil, Robert B M Landewé
The favourable long-term results of early treatment in patients with classified rheumatoid arthritis have resulted in an increasing interest in the diseases phases preceding clinical arthritis. The hypothesis to test is that an intervention in these early phases may better prevent or reduce disease persistence than an intervention when arthritis has become clinically manifest. While several placebo-controlled trials are still ongoing, to date there is no firm evidence that this hypothesis truly holds. Therefore, it is important to reflect on the current status of arthralgia preceding clinical arthritis...
January 8, 2020: Annals of the Rheumatic Diseases
#5
Mary Canavan, Sarah M Wade, Douglas J Veale, Ursula Fearon
No abstract text is available yet for this article.
January 8, 2020: Annals of the Rheumatic Diseases
#6
John G Hanly, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann E Clarke, Daniel J Wallace, David A Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askanase, Vernon Farewell
OBJECTIVES: Using a reversible multistate model, we prospectively examined neuropsychiatric (NP) events for attribution, outcome and association with health-related quality of life (HRQoL), in an international, inception cohort of systemic lupus erythematosus (SLE) patients. METHODS: Annual assessments for 19 NP events attributed to SLE and non-SLE causes, physician determination of outcome and patient HRQoL (short-form (SF)-36 scores) were measured. Time-to-event analysis and multistate modelling examined the onset, recurrence and transition between NP states...
January 8, 2020: Annals of the Rheumatic Diseases
#7
LETTER
Fulvia Ceccarelli, Andrea Botticelli, Alain Jonathan Gelibter, Ilaria Leccese, Ramona Lucchetti, Enrico Cortesi, Guido Valesini, Paolo Marchetti, Fabrizio Conti
No abstract text is available yet for this article.
January 6, 2020: Annals of the Rheumatic Diseases
#8
Kornelis S M van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta
OBJECTIVES: Ultrasound of temporal and axillary arteries may reveal vessel wall inflammation in patients with giant cell arteritis (GCA). We developed a ultrasound scoring system to quantify the extent of vascular inflammation and investigated its diagnostic accuracy and association with clinical factors in GCA. METHODS: This is a prospective study including 89 patients suspected of having GCA, of whom 58 had a confirmed clinical diagnosis of GCA after 6 months follow-up...
January 3, 2020: Annals of the Rheumatic Diseases
#9
Xenofon Baraliakos, Adrian Richter, Carsten O Schmidt, Juergen Braun
No abstract text is available yet for this article.
January 3, 2020: Annals of the Rheumatic Diseases
#10
EDITORIAL
Leonard Calabrese, Xavier Mariette
No abstract text is available yet for this article.
January 3, 2020: Annals of the Rheumatic Diseases
#11
LETTER
Keisuke Maeshima, Hirotaka Shibata
No abstract text is available yet for this article.
January 3, 2020: Annals of the Rheumatic Diseases
#12
Emmanuel Monnet, Ernest H Choy, Iain McInnes, Tamta Kobakhidze, Kathy de Graaf, Philippe Jacqmin, Geneviève Lapeyre, Cristina de Min
OBJECTIVES: Anti-citrullinated protein antibodies (ACPAs) form immune complexes with citrullinated proteins binding toll-like receptor (TLR) 4, which has been proposed as a mediator of rheumatoid arthritis (RA). NI-0101 is a first-in-class humanised monoclonal antibody blocking TLR4, as confirmed by inhibition of in vivo lipopolysaccharide-induced cytokine release in healthy volunteers. This study was design to confirm preclinical investigations supporting a biomarker-driven approach for treatment of patients with RA who present positive for these immune complexes...
December 31, 2019: Annals of the Rheumatic Diseases
#13
Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson
No abstract text is available yet for this article.
December 31, 2019: Annals of the Rheumatic Diseases
#14
LETTER
Cristina Regueiro, Antonio Gonzalez
No abstract text is available yet for this article.
December 31, 2019: Annals of the Rheumatic Diseases
#15
LETTER
Antoine Fayand, Veronique Hentgen, Stephanie Ducharme-Bénard, Pierre Quartier, Brigitte Bader-Meunier, Isabelle Koné-Paut, Gilles Grateau, Sophie Georgin-Lavialle
No abstract text is available yet for this article.
December 31, 2019: Annals of the Rheumatic Diseases
#16
Hao Sun, Xingzhao Wen, Hongyi Li, Peihui Wu, Minghui Gu, Xiaoyi Zhao, Ziji Zhang, Shu Hu, Guping Mao, Ruofan Ma, Weiming Liao, Zhiqi Zhang
OBJECTIVES: The heterogeneity of meniscus cells and the mechanism of meniscus degeneration is not well understood. Here, single-cell RNA sequencing (scRNA-seq) was used to identify various meniscus cell subsets and investigate the mechanism of meniscus degeneration. METHODS: scRNA-seq was used to identify cell subsets and their gene signatures in healthy human and degenerated meniscus cells to determine their differentiation relationships and characterise the diversity within specific cell types...
December 23, 2019: Annals of the Rheumatic Diseases
#17
Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir, Thérèse Croughs, Michael Lucas Tee
OBJECTIVE: To evaluate the efficacy and safety of the immunotherapeutic vaccine interferon-α kinoid (IFN-K) in a 36-week (W) phase IIb, randomised, double-blind, placebo (PBO)-controlled trial in adults with active systemic lupus erythematosus (SLE) despite standard of care. METHODS: Patients with SLE (185) with moderate to severe disease activity and positive interferon (IFN) gene signature were randomised to receive IFN-K or PBO intramuscular injections (days 0, 7 and 28 and W12 and W24)...
December 23, 2019: Annals of the Rheumatic Diseases
#18
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson
No abstract text is available yet for this article.
December 20, 2019: Annals of the Rheumatic Diseases
#19
LETTER
Smriti K Raychaudhuri, Christine Abria, Siba P Raychaudhuri
No abstract text is available yet for this article.
December 20, 2019: Annals of the Rheumatic Diseases
#20
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson
No abstract text is available yet for this article.
December 20, 2019: Annals of the Rheumatic Diseases
Fetching more papers... 
